LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 12.00
-1.05 (-8.05%)
Aug 19, 2026, 11:29 AM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 423.53 million as of August 18, 2026. Its market cap has decreased by -44.94% in one year.
Market Cap
423.53M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.00
ChartMarket Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 423.53M, a decrease of -41.26%. That is a compound annual growth rate of -18.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 446.25M | -41.24% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 834.99M |
| NatureWise Biotech & Medicals | 786.46M |
| Taiwan Advance Bio-Pharmaceutical | 783.00M |
| BioLASCO Taiwan | 760.68M |
| SynCore Biotechnology Co.,Ltd | 683.95M |
| MegaPro Biomedical | 666.63M |
| Neith | 633.14M |
| TaiwanJ Pharmaceuticals | 546.43M |